GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹46.90 | ₹47.42 | ₹73.75 | ₹60.94 | ₹49.88 |
What is the latest Earnings Per Share (EPS) of GLAND PHARMA ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹46.90 |
| Mar2024 | ₹47.42 |
| Mar2023 | ₹73.75 |
| Mar2022 | ₹60.94 |
| Mar2021 | ₹49.88 |
How is Earnings Per Share (EPS) of GLAND PHARMA Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹46.90 | -1.10 | |
| Mar2024 | ₹47.42 | -35.70 | |
| Mar2023 | ₹73.75 | 21.02 | |
| Mar2022 | ₹60.94 | 22.17 | |
| Mar2021 | ₹49.88 | - | |
Compare Earnings Per Share (EPS) of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹38,123.2 Cr | -1% | 30.5% | 49.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,677.0 Cr | -2.4% | 6.4% | 7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,458.0 Cr | -0.9% | 5% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹153,685.0 Cr | 1.6% | 7.6% | 38.5% | Stock Analytics | |
| CIPLA | ₹114,562.0 Cr | 1.2% | 7.7% | -3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,095.0 Cr | 0.1% | -1.2% | 8.7% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -1% |
30.5% |
49.4% |
| SENSEX | 0.7% |
-1% |
-7% |
You may also like the below Video Courses